Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M P Schlaich

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Diabetologia|March 29, 2011
Angiotensin receptor blockade in diabetic women of childbearing potential: an acceptable risk?M P Schlaich
Minerva Cardioangiologica|November 28, 2009
Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammationT Dawood, M P Schlaich
Deutsche Medizinische Wochenschrift (1946)|March 28, 2003
[Sympathetic nerve activity in essential hypertension. New pathophysiologic aspects]M P Schlaich, M D Esler
American Journal of Hypertension|December 1, 1998
Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agentsM P Schlaich, R E Schmieder
Advances in Experimental Medicine and Biology|January 1, 1997
Comparison of therapeutic studies on regression of left ventricular hypertrophyR E Schmieder, M P Schlaich
Diabetologia|July 20, 2007
Brain derived neurotrophic factor (BDNF) release from the human brain in patients with type 2 diabetes--possible influence of venous anatomy and comorbid major depressive disorderG W Lambert, M P Schlaich, M D Esler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 1998
Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)R E Schmieder, M P Schlaich, A U Klingbeil, et al.
The American Journal of Cardiology|May 10, 2000
Impact of aldosterone on left ventricular structure and function in young normotensive and mildly hypertensive subjectsM P Schlaich, H P Schobel, K Hilgers, et al.
Microvascular Research|April 10, 2012
Rosuvastatin improves pulse wave reflection by restoring endothelial functionC Ott, M P Schneider, M P Schlaich, et al.
Journal of Human Hypertension|November 22, 2013
Substantial blood pressure reduction with renal denervation in a drug-naïve patient intolerant to antihypertensive pharmacotherapy: a case reportJ Xu, A Walton, D Hering, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Diabetologia|March 29, 2011
Angiotensin receptor blockade in diabetic women of childbearing potential: an acceptable risk?M P Schlaich
Minerva Cardioangiologica|November 28, 2009
Mediators of target organ damage in hypertension: focus on obesity associated factors and inflammationT Dawood, M P Schlaich
Deutsche Medizinische Wochenschrift (1946)|March 28, 2003
[Sympathetic nerve activity in essential hypertension. New pathophysiologic aspects]M P Schlaich, M D Esler
American Journal of Hypertension|December 1, 1998
Left ventricular hypertrophy and its regression: pathophysiology and therapeutic approach: focus on treatment by antihypertensive agentsM P Schlaich, R E Schmieder
Advances in Experimental Medicine and Biology|January 1, 1997
Comparison of therapeutic studies on regression of left ventricular hypertrophyR E Schmieder, M P Schlaich
Diabetologia|July 20, 2007
Brain derived neurotrophic factor (BDNF) release from the human brain in patients with type 2 diabetes--possible influence of venous anatomy and comorbid major depressive disorderG W Lambert, M P Schlaich, M D Esler
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 29, 1998
Update on reversal of left ventricular hypertrophy in essential hypertension (a meta-analysis of all randomized double-blind studies until December 1996)R E Schmieder, M P Schlaich, A U Klingbeil, et al.
The American Journal of Cardiology|May 10, 2000
Impact of aldosterone on left ventricular structure and function in young normotensive and mildly hypertensive subjectsM P Schlaich, H P Schobel, K Hilgers, et al.
Microvascular Research|April 10, 2012
Rosuvastatin improves pulse wave reflection by restoring endothelial functionC Ott, M P Schneider, M P Schlaich, et al.
Journal of Human Hypertension|November 22, 2013
Substantial blood pressure reduction with renal denervation in a drug-naïve patient intolerant to antihypertensive pharmacotherapy: a case reportJ Xu, A Walton, D Hering, et al.
Pageof 4